Optimizing Clinical Trial Design for Patients with Non-muscle-invasive Bladder Cancer

Eur Urol. 2022 Jul;82(1):47-48. doi: 10.1016/j.eururo.2022.02.014. Epub 2022 Mar 15.

Authors

Chana Weinstock¹, Sundeep Agrawal², Elaine Chang²

Affiliations

¹ Department of Oncology, United States Food and Drug Administration, Silver Spring, MD, USA. Electronic address: [email protected].
² Department of Oncology, United States Food and Drug Administration, Silver Spring, MD, USA.

PMID: 35304001
DOI: 10.1016/j.eururo.2022.02.014

No abstract available

Publication types

Editorial
Comment

MeSH terms

Clinical Trials as Topic*
Humans
Neoplasm Invasiveness
Research Design
Urinary Bladder Neoplasms* / drug therapy
Urinary Bladder Neoplasms* / pathology